Clinical Trial Update: Vorapaxar on Thrombin Generation and Coagulability [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating vorapaxar's impact on thrombin generation and coagulability in patients with coronary artery disease and peripheral vascular dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Peripheral Vascular Disease

Drugs mentioned

• Vorapaxar (vorapaxar)

Snippet

Sponsor: Inova Health Care Services | Conditions: Coronary Artery Disease, Peripheral Vascular Disease | Phase 4 | Status: COMPLETED | Results posted: 2022-08-18